Heart Test Laboratories
HSCS
10 hedge funds and large institutions have $232K invested in Heart Test Laboratories in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 10 → 10 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.9% less ownership
Funds ownership: 5.88% → 4.98% (-0.9%)
33% less capital inflows, than outflows
Capital inflows: $128K | Capital outflows: $192K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Astoria Strategic Wealth
Conroe,
Texas
|
+$45.2K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$32.8K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$23.7K |
| 4 |
Virtu Financial
New York
|
+$19.9K |
| 5 |
HRT Financial
New York
|
+$6.13K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$78K |
| 2 |
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
|
-$33.6K |
| 3 |
Renaissance Technologies
New York
|
-$32K |
| 4 |
AE Wealth Management
Topeka,
Kansas
|
-$31.9K |
| 5 |
Two Sigma Securities
New York
|
-$15.8K |
HSCS Hedge Fund Activity: Q3 2023 in Review
10 of the 6,316 institutional investors tracked by Wall St. Rank reported a position in Heart Test Laboratories (HSCS) for Q3 2023, worth a combined $232K — down 57% from $545K a quarter earlier.
Fund positioning in HSCS was balanced in Q3 2023: 4 funds opened new positions, 4 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Astoria Strategic Wealth, adding an estimated $45.2K. The largest seller was Royal Bank of Canada, exiting entirely with an estimated $78K sold.
- 10 institutional investors held Heart Test Laboratories (HSCS) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $232K of Heart Test Laboratories stock for Q3 2023, down 57% quarter-over-quarter.
- 4 funds opened new Heart Test Laboratories positions in Q3 2023 and 4 closed out, a net change of 0 holders.
- The largest Heart Test Laboratories buyer in Q3 2023 was Astoria Strategic Wealth, an estimated $45.2K added.
- The largest Heart Test Laboratories seller in Q3 2023 was Royal Bank of Canada, an estimated $78K sold.
Based on aggregated 13F filings for Q3 2023.